Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
MicroTech Medical (Hangzhou) Co., Ltd. Class H ( (HK:2235) ) has issued an update.
MicroTech Medical (Hangzhou) Co., Ltd., a Hong Kong-listed medical technology company, has a board that includes executive, non-executive and independent non-executive directors, led by chairman Zheng Pan. This structure underpins its compliance with capital market governance norms and supports oversight of its financial and strategic planning.
The company has scheduled a board meeting for March 30, 2026 to review and approve its audited annual results for the year ended December 31, 2025, and to decide on the publication of those results. The board will also consider recommending a final dividend, if any, signaling a forthcoming decision on shareholder returns and providing investors with visibility on the company’s financial disclosure timetable.
The most recent analyst rating on (HK:2235) stock is a Sell with a HK$7.00 price target. To see the full list of analyst forecasts on MicroTech Medical (Hangzhou) Co., Ltd. Class H stock, see the HK:2235 Stock Forecast page.
More about MicroTech Medical (Hangzhou) Co., Ltd. Class H
MicroTech Medical (Hangzhou) Co., Ltd. is a mainland China-based medical technology company listed in Hong Kong under stock code 2235. The firm operates through a board comprising executive, non-executive and independent non-executive directors, reflecting a standard listed-company governance structure aimed at overseeing its operations and strategic decisions.
Average Trading Volume: 114,158
Technical Sentiment Signal: Hold
Current Market Cap: HK$3.03B
See more insights into 2235 stock on TipRanks’ Stock Analysis page.